New Product Release
Genovis launches FragIT, a self-drained column for fragmentation of larger quantities of IgG. The immobilized enzyme FabRICATOR® generate precise F(ab’)2 and Fc fragments in less than 30 minutes. This new antibody engineering tool is targeting pharma-, biotechnology- and diagnostic companies that develop antibody based drugs and analysis.
Read more at: www.genovis.com/fragit
The Product Release is attached and published at Genovis web site: www.genovis.com
Find out more, contact: Sarah Fredriksson, CEO, Genovis AB Tel: +46 46 10 12 35
Genovis is a biotech company on the leading edge of nanotechnology and nanoparticles. The company’s patented nano-induced magnetic transfer (NIMT®) technology was developed to facilitate effective preclinical research for the life science industry. Genovis shares are listed on Nasdaq OMX First North and Thenberg & Kinde Fondkommission is our certified adviser.